The Insulin Receptor Tyrosine Kinase Substrate p58/53 and the Insulin Receptor Are Components of CNS Synapses

No abstract is available for this paper.

• Publication year

  1999

• Venue

  Journal of Neuroscience

• Publication date

  1999-09-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1523/JNEUROSCI.19-17-07300.1999PMID 10460236PMCID PMC6782521
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The IRS-signaling system: a network of docking proteins that mediate insulin and cytokine action.

  1998cited by this paper
• Insulin-degrading Enzyme Regulates Extracellular Levels of Amyloid β-Protein by Degradation*

  1998cited by this paper
• Phosphoinositide 3-kinase: the key switch mechanism in insulin signalling.

  1998cited by this paper
• Intracerebroventricular administration of streptozotocin causes long-term diminutions in learning and memory abilities and in cerebral energy metabolism in adult rats.

  1998cited by this paper
• Tracking Insulin to the Mind

  1998cited by this paper
• CPEB-mediated cytoplasmic polyadenylation and the regulation of experience-dependent translation of alpha-CaMKII mRNA at synapses.

  1998influential reference
• The IRS-signaling system: a network of docking proteins that mediate insulin and cytokine action.

  1998cited by this paper
• Salient features of synaptic organisation in the cerebral cortex.

  1998cited by this paper
• Is sporadic Alzheimer disease the brain type of non-insulin dependent diabetes mellitus? A challenging hypothesis

  1998cited by this paper
• Brain insulin and insulin receptors in aging and sporadic Alzheimer's disease

  1998cited by this paper
• Different Subcellular Distribution and Regulation of Expression of Insulin Receptor Substrate (IRS)-3 from Those of IRS-1 and IRS-2*

  1998cited by this paper
• Disruption of a putative SH3 domain and the proline‐rich motifs in the 53‐kDa substrate of the insulin receptor kinase does not alter its subcellular localization or ability to serve as a substrate

  1998cited by this paper
• Recruitment of functional GABAA receptors to postsynaptic domains by insulin

  1997cited by this paper
• Insulin Receptor Substrate (IRS)-1 and IRS-2 Are Tyrosine-phosphorylated and Associated with Phosphatidylinositol 3-Kinase in Response to Brain-derived Neurotrophic Factor in Cultured Cerebral Cortical Neurons*

  1997cited by this paper
• The postsynaptic density at glutamatergic synapses.

  1997cited by this paper
• Insulin and Insulin-like Growth Factor-1 Regulate Tau Phosphorylation in Cultured Human Neurons*

  1997cited by this paper
• Excitatory synapses. Glutamate receptors put in their place.

  1997cited by this paper
• Ion channel targeting in neurons

  1997cited by this paper
• Glutamate receptors put in their place

  1997cited by this paper
• Enlightening the Postsynaptic Density Review

  1997cited by this paper
• Characterization and Cloning of a 58/53-kDa Substrate of the Insulin Receptor Tyrosine Kinase (*)

  1996influential reference
• Preproinsulin I and II mRNAs and insulin electron microscopic immunoreaction are present within the rat fetal nervous system.

  1996cited by this paper
• β‐Dystroglycan: Subcellular Localisation in Rat Brain and Detection of a Novel Immunologically Related, Postsynaptic Density‐Enriched Protein

  1996cited by this paper
• The β-Adrenergic Receptor Is a Substrate for the Insulin Receptor Tyrosine Kinase (*)

  1996cited by this paper
• Memory improvement following induced hyperinsulinemia in Alzheimer's disease.

  1996cited by this paper
• Long-lasting neurotrophin-induced enhancement of synaptic transmission in the adult hippocampus

  1995cited by this paper
• Identification of a major autophosphorylation site on postsynaptic density-associated Ca2+/calmodulin-dependent protein kinase.

  1994cited by this paper
• Insulin receptor substrate-1 (IRS-1) distribution in the rat central nervous system

  1994cited by this paper
• Insulin receptor substrate-1 (IRS-1) expression in rat brain.

  1994cited by this paper
• The cellular and physiological actions of insulin in the central nervous system.

  1993cited by this paper
• Inhibition of Endogenous Phosphatase in a Postsynaptic Density Fraction Allows Extensive Phosphorylation of the Major Postsynaptic Density Protein

  1993cited by this paper
• Synaptic structure and development: the neuromuscular junction.

  1993cited by this paper
• A dystrophin-associated glycoprotein, A3a (one of 43DAG doublets), is retained in Duchenne muscular dystrophy muscle.

  1993cited by this paper
• Potentiation of developing neuromuscular synapses by the neurotrophins NT-3 and BDNF

  1993cited by this paper
• The distribution of synapsin I and synaptophysin in hippocampal neurons developing in culture

  1991influential reference
• The fine structure of the nervous system

  1991cited by this paper
• Basic local alignment search tool.

  1990cited by this paper
• Release of Immunoreactive Insulin from Rat Brain Synaptosomes Under Depolarizing Conditions

  1990cited by this paper
• Distribution of insulin receptor-like immunoreactivity in the rat forebrain.

  1989cited by this paper
• Distribution of αlatrotoxin receptor in the rat brain by quantitative autoradiography: Comparison with the nerve terminal protein, synapsin I

  1989cited by this paper
• Vertebrate neuromuscular junctions: general morphology, molecular organization, and functional consequences

  1987cited by this paper
• Insulin Is Released from Rat Brain Neuronal Cells in Culture

  1986cited by this paper
• Structural differences between insulin receptors in the brain and peripheral target tissues.

  1983cited by this paper
• Silver stain for proteins in polyacrylamide gels: a modified procedure with enhanced uniform sensitivity.

  1981cited by this paper
• Isolation and characterization of postsynaptic densities from various brain regions: enrichment of different types of postsynaptic densities

  1980cited by this paper

• Insulin resistance in Alzheimer's disease: signalling mechanisms and therapeutics strategies

  2025cites this paper
• Single-cell long-read sequencing of the experience-induced transcriptome

  2025cites this paper
• Metabolic and Immune System Dysregulation: Unraveling the Connections between Alzheimer’s Disease, Diabetes, Inflammatory Bowel Diseases, and Rheumatoid Arthritis

  2024cites this paper
• Diabetes mellitus and Alzheimer's disease: Vacuolar adenosine triphosphatase as a potential link

  2024cites this paper
• Association of triglyceride glucose index combined with obesity indicators with cognitive impairment

  2024cites this paper
• Variable bioenergetic sensitivity of neurons and astrocytes to insulin and extracellular glucose

  2024cites this paper
• Investigating the molecular mechanisms between type 1 diabetes and mild cognitive impairment using bioinformatics analysis, with a focus on immune response.

  2024cites this paper
• Potential molecular mechanism of exercise reversing insulin resistance and improving neurodegenerative diseases

  2024cites this paper
• Physiological Mechanisms Inherent to Diabetes Involved in the Development of Dementia: Alzheimer’s Disease

  2023cites this paper
• Beneficial effects of Insulin and Rivastigmine in Type-3 Diabetes mellitus in rats

  2023cites this paper
• Hippocampal BAIAP2 prevents chronic mild stress-induced depression-like behaviors in mice

  2023cites this paper
• Brain insulin signaling and cognition: Possible links

  2023cites this paper
• Brain Insulin Signaling is Associated with Late-Life Cognitive Decline

  2023cites this paper
• Brain Insulin Signaling as A Potential Mediator of Early Life Adversity Effects on Physical and Mental Health.

  2023cites this paper
• Insulin and Disorders of Behavioural Flexibility.

  2023influential citation
• The Expression of Insulin in the Central Nervous System: What Have We Learned So Far?

  2023cites this paper
• Loss of brain energy metabolism control as a driver for memory impairment upon insulin resistance.

  2023cites this paper
• Changes in the structure, perfusion, and function of the hippocampus in type 2 diabetes mellitus

  2023cites this paper
• Cognitive benefits of Sodium-Glucose Co-Transporters-2 Inhibitors in the Diabetic Milieu.

  2023cites this paper
• Dysmetabolism and Neurodegeneration: Trick or Treat?

  2022cites this paper
• Autonomous regulation of retinal insulin biosynthesis in diabetes.

  2022cites this paper
• Is the Brain Undernourished in Alzheimer’s Disease?

  2022cites this paper
• Central Adiponectin Signaling – A Metabolic Regulator in Support of Brain Plasticity

  2022cites this paper
• Type 2 Diabetes and Parkinson's Disease: A Focused Review of Current Concepts

  2022cites this paper
• Impaired insulin signalling and allostatic load in Alzheimer disease

  2022cites this paper
• Diabetes: Risk factor and translational therapeutic implications for Alzheimer's disease

  2022cites this paper
• Potential Roles of Glucagon-Like Peptide-1 and Its Analogues in Dementia Targeting Impaired Insulin Secretion and Neurodegeneration

  2022cites this paper
• Clinical Study of Neurodegenerative Treatment on Glaucoma by Insulin Intravitreal Injection

  2022cites this paper
• Combined exposure of lead and high-fat diet enhanced cognitive decline via interacting with CREB-BDNF signaling in male rats.

  2022cites this paper
• Cognitive Impairment in Type 2 Diabetes Mellitus

  2022cites this paper
• Identification of TRAPPC9 and BAIAP2 Gene Polymorphisms and Their Association With Fat Deposition-Related Traits in Hu Sheep

  2022cites this paper
• Vitamin D and rosuvastatin alleviate type-II diabetes-induced cognitive dysfunction by modulating neuroinflammation and canonical/noncanonical Wnt/β-catenin signaling

  2022cites this paper
• Adult re-expression of IRSp53 rescues NMDA receptor function and social behavior in IRSp53-mutant mice

  2022cites this paper
• Influence of Genetic and Cardiometabolic Risk Factors in Alzheimer's Disease.

  2022cites this paper
• Systems-level investigation of mucopolysaccharidosis IIIA identifies deficient synaptic activity as a key driver of disease progression

  2022cites this paper
• Nutritional and developmental programming effects of insulin

  2021cites this paper
• Effect of Caloric Restriction on Aging: Fixing the Problems of Nutrient Sensing in Postmitotic Cells?

  2021cites this paper
• Insulin on the brain: The role of central insulin signalling in energy and glucose homeostasis

  2021cites this paper
• BVVL / FL : Features caused by SLC 52 A 3 mutations ; WDFY 4 and TNFSF 13 B may be 1 novel causative genes 2

  2021cites this paper
• Alzheimer’s Disease and Type 2 Diabetes Mellitus: The Use of MCT Oil and a Ketogenic Diet

  2021cites this paper
• The Effect of Type-2 Diabetes on Cognitive Status and the Role of Anti-diabetes Medications

  2021cites this paper
• Evaluation of Effect of Ninjin'yoeito on Regional Brain Glucose Metabolism by 18F-FDG Autoradiography With Insulin Loading in Aged Mice

  2021cites this paper
• Insulin and Insulin Resistance in Alzheimer’s Disease

  2021cites this paper
• Brain Insulin Resistance: Focus on Insulin Receptor-Mitochondria Interactions

  2021cites this paper
• Endocrine Factors in Key Structural and Intracellular Changes in Depression.

  2021cites this paper
• Revisiting I-BAR Proteins at Central Synapses

  2021cites this paper
• Alzheimer's Disease and Protein Kinases.

  2021cites this paper
• Verapamil Prevents Development of Cognitive Impairment in an Aged Mouse Model of Sporadic Alzheimer’s Disease

  2021cites this paper
• Cross-Talk of the Glutamate and Leptin Receptor Pathways

  2021cites this paper
• Maternal stressors and the developmental origins of neuropsychiatric risk.

  2020cites this paper
• Maternal high fat diet multigenerationally impairs hippocampal synaptic plasticity and memory in male rat offspring.

  2020cites this paper
• Intranasal applications in Alzheimer's treatment

  2020cites this paper
• An update on potential links between type 2 diabetes mellitus and Alzheimer’s disease

  2020cites this paper
• Neuroinflammation, microglial activation, and glucose metabolism in neurodegenerative diseases.

  2020cites this paper
• AMPK: a bridge between diabetes mellitus and Alzheimer's disease.

  2020cites this paper
• Neurodevelopmental Disorders: Effect of High-Fat Diet on Synaptic Plasticity and Mitochondrial Functions

  2020cites this paper
• Obesity and Diabetes: Implications for Brain-Immunometabolism

  2020cites this paper
• Brain insulin resistance impairs hippocampal plasticity.

  2020cites this paper
• Antagonistic regulation by insulin-like peptide and activin ensures the elaboration of appropriate dendritic field sizes of amacrine neurons

  2020influential citation
• Modulation of MicroRNAs as a Potential Molecular Mechanism Involved in the Beneficial Actions of Physical Exercise in Alzheimer Disease

  2020cites this paper
• Maternal high-fat diet results in cognitive impairment and hippocampal gene expression changes in rat offspring.

  2019cites this paper
• EPS 8 , an Adaptor Protein Acts as an Oncoprotein in Human Cancer

  2019cites this paper
• Tau, Diabetes and Insulin.

  2019cites this paper
• The Involvement of Peripheral and Brain Insulin Resistance in Late Onset Alzheimer’s Dementia

  2019cites this paper
• Insulin Protects Cortical Neurons Against Glutamate Excitotoxicity

  2019cites this paper
• Multi-Loop Model of Alzheimer Disease: An Integrated Perspective on the Wnt/GSK3β, α-Synuclein, and Type 3 Diabetes Hypotheses

  2019cites this paper
• RIP at the Synapse and the Role of Intracellular Domains in Neurons

  2019cites this paper
• Loss of Bardet-Biedl syndrome proteins causes synaptic aberrations in principal neurons

  2019cites this paper
• Time-response studies on development of cognitive deficits in an experimental model of insulin resistance.

  2019cites this paper
• Insulin and Autophagy in Neurodegeneration

  2019cites this paper
• Role of the Blood-Brain Barrier in Central Nervous System Insulin Resistance

  2019cites this paper
• Spatial dynamics of the insulin receptor in living neurons

  2019cites this paper
• Altered Insulin Signaling in Alzheimer’s Disease Brain – Special Emphasis on PI3K-Akt Pathway

  2019cites this paper
• The diabetes drug liraglutide reverses cognitive impairment in mice and attenuates insulin receptor and synaptic pathology in a non‐human primate model of Alzheimer's disease

  2018cites this paper
• Expression of a Constitutively Active Human Insulin Receptor in Hippocampal Neurons Does Not Alter VGCC Currents

  2018cites this paper
• Mutual Relationship between Tau and Central Insulin Signalling: Consequences for AD and Tauopathies?

  2018cites this paper
• Evidence for altered insulin receptor signaling in Alzheimer's disease

  2018cites this paper
• Brain insulin resistance in type 2 diabetes and Alzheimer disease: concepts and conundrums

  2018cites this paper
• Mechanism involved in insulin resistance via accumulation of β -amyloid and neurofibrillary tangles: link between type 2 diabetes and Alzheimer’s disease

  2018cites this paper
• Mechanism involved in insulin resistance via accumulation of β -amyloid and neurofibrillary tangles: link between type 2 diabetes and Alzheimer’s disease

  2018cites this paper
• SMPL Synaptic Membranes: Nanodisc-Mediated Synaptic Membrane Mimetics Expand the Toolkit for Drug Discovery and the Molecular Cell Biology of Synapses

  2018cites this paper
• Mechanism involved in insulin resistance via accumulation of β -amyloid and neurofibrillary tangles: link between type 2 diabetes and Alzheimer’s disease

  2018cites this paper
• Insulin receptor in the brain: Mechanisms of activation and the role in the CNS pathology and treatment

  2018cites this paper
• Altered Expression of Metabolic Proteins Contributes to Neuropathological Disease

  2018cites this paper
• Mechanism involved in insulin resistance via accumulation of β-amyloid and neurofibrillary tangles: link between type 2 diabetes and Alzheimer’s disease

  2018cites this paper
• An Evaluation of Alzheimer's Disease-related Pathology in Two Different Models of Diabetes in Immune-challenged Mice

  2018cites this paper
• Dendritic spine actin cytoskeleton in autism spectrum disorder.

  2017cites this paper
• Synaptic Plasticity, Dementia and Alzheimer Disease.

  2017cites this paper
• Insulin Resistance and Alzheimer’s Disease: Bioenergetic Linkages

  2017cites this paper
• Obesity and insulin resistance are associated with reduced activity in core memory regions of the brain

  2017cites this paper
• Hippocampal insulin resistance and altered food decision-making as players on obesity risk.

  2017cites this paper
• Diabetes Type 4: A Paradigm Shift in the Understanding of Glaucoma, the Brain Specific Diabetes and the Candidature of Insulin as a Therapeutic Agent.

  2017cites this paper
• GLUT4 Mobilization Supports Energetic Demands of Active Synapses.

  2017cites this paper
• The neuronal insulin receptor in its environment

  2017cites this paper
• Salt Bridge Formation between the I-BAR Domain and Lipids Increases Lipid Density and Membrane Curvature

  2017cites this paper
• Insulin Resistance Disrupts the Interaction Between AKT and the NMDA Receptor and the Inactivation of the CaMKIV/CREB Pathway in Minimal Hepatic Encephalopathy.

  2017cites this paper
• INSULIN ACTIONS ON HIPPOCAMPAL NEURONS

  2017cites this paper
• IRSp53 accumulates at the postsynaptic density under excitatory conditions

  2017cites this paper
• Insulin Resistance Disrupts the Interaction Between AKT and the NMDA Receptor and the Inactivation of the CaMKIV/CREB Pathway in Minimal Hepatic Encephalopathy

  2017cites this paper
• An Evaluation of GABAB Receptors on Modulating Neuroinflammation in a Non-~Transgenic Animal Model of Alzheimer's Disease

  2017cites this paper